GlassScriptPhysician profile
Baldeep Kaur Mann
NPI 1013438837
$368.43
in general payments reported to CMS, 2019-2025
11 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.48 · 2020: $25.22 · 2021: $68.93 · 2022: $47.40 · 2023: $65.70 · 2024: $30.79 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $58.82 | 2025 | Opsynvi, Uptravi |
| Dynavax Technologies Corporation | $48.32 | 2021 | |
| Novo Nordisk INC | $45.61 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $42.85 | 2025 | |
| Astellas Pharma US INC | $41.97 | 2022-2023 | Cresemba |
| Janssen Pharmaceuticals, INC | $38.48 | 2020-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $32.79 | 2023 | Lifevest |
| Alkermes, INC. | $17.53 | 2024 | Vivitrol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.24 | 2025 | |
| Coloplast Corp | $13.34 | 2023 | Altis |
| Pfizer INC. | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Baldeep Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.